Paul S. Berry
From Wikipedia, the free encyclopedia
Paul S. Berry (born September 24, 1957) is a noted investigator of HIV.
He graduated from The George Washington University with a medical degree. He has a MBA from UC Irvine and a Juris Doctor Degree from [UC Berkeley] [Boalt Hall].
He created the model used for HIV clinical research done in the setting of primary care physician's offices. In conjunction with Roche Molecular Systems, he pioneered the commercialization of HIV-1 viral quantification via Amplicor. He performed the viral load testing for Merck data submission to FDA for approval of Crixivan.
Dr. Berry served as principal investigator [1][2][3][4] on more than 50 phase II-IV HIV-1 clinical studies providing consistent, reliable data leading to FDA approval of lamivudine, indinavir, ritonavir and saquinavir. Dr. Berry is also the host of MedTalk and HearTalk radio talk show.
